1. Principles of basic and clinical endocrinology
1.1: Lynn Loriaux: Endocrine Practice Fundamentals
1.2: John W. Funder: Hormones and receptors: fundamental considerations
1.3: Ken Siddle and Gemma Brierley: Molecular aspects of hormonal regulation
1.4: Janine A. Danks and Samantha J. Richardson: Endocrinology and evolution: lessons from comparative endocrinology
1.5: James Gibney, Indi Banerjee, and Ken Ho: Hormones Across the Lifespan
1.6: Brian Keevil, Peter Trainer, and William Drake: Pituitary assessment strategy
1.7: Simon Pearce and Catherine Owen: Endocrine autoimmunity
1.8: Jerome Bertherat, Anne Jouinot, and Fidéline Bonnet-Serrano: Common Features of Endocrine Tumours
1.9: Trevor Cole: Genetic Aspects of Endocrine Disease
1.10: George Mastorakos, Markella Nezi, Djuro Macut, and Maria Papagianni: Environmental Influences on Endocrine Disease
1.11: Georg Brabant and H. Oster: Endocrinology, sleep and circadian rhythms
1.12: Richard Ross: Principles of Hormone replacement
1.13: Jonathan Valabhji and Rochan Agha-Jaffar: Prevention in endocrinology
2. Pituitary and hypothalamic diseases
2.1: John Morris: Functional anatomy of the hypothalamus and pituitary
2.2: Stephen G. Ball: The neurohypophysis
2.3: Aetiology, pathogenesis, and management of disease of the pituitary
2.3.1: Mehul T. Dattani and Louise C. Gregory: Development of the pituitary and genetic forms of hypopituitarism
2.3.2: Shlomo Melmed: Molecular pathogenesis of pituitary tumours
2.3.3: Luis Syro, Kalman Kovacs, and Fabio Rotondo: Histopathology of pituitary tumours
2.3.4: Jean-Francois Bonneville, Sonia Nagi, and Iulia Potorac: Imaging of the pituitary
2.3.5: Miles J. Levy, Ragini Bhake, and Narendra Reddy: Hypopituitarism: replacement of adrenal, thyroid, and gonadal axes
2.3.6: Jens Jørgensen: Adult growth hormone deficiency
2.3.7: Edward R. Laws Jr, David L. Penn, and Caroline S. Repetti: Surgery of pituitary tumours
2.3.8: Naomi Fersht and Francesca Solda: Pituitary radiotherapy
2.3.9: Nicholas Tritos and Anne Klibanski: Prolactinomas and hyperprolactinaemia (including macroprolactinaemia)
2.3.10: John Wass, Peter J. Trainer, and Márta Korbonits: Acromegaly
2.3.11: Nienke Biermasz and Wouter R. van Furth: Clinically nonfunctioning pituitary tumours and gonadotropinomas
2.3.12: Mark Gurnell, Olympia Koulouri, and Waiel Bashari: Thyrotropinomas
2.3.13: Ann McCormack: Pituitary carcinoma
2.3.14: Niki Karavitaki, Shu Teng Chai, and Shahzada Ahmed: Pituitary incidentalomas
2.4: Aetiology, pathogenesis, and management of diseases of the hypothalamus
2.4.1: Mehul Dattani, Hoong-Wei Gan, and Manuela Cerbone: Hypothalamic dysfunction (hypothalamic syndromes)
2.4.2: Niki Karavitaki: Craniopharyngiomas
2.4.3: Jürgen Honegger, Ulrike Ernemann, and Rudi Beschorner: Perisellar tumours including cysts, hamartomas, and vascular tumours
2.4.4: Mark E. Molitch and Jelena Kravarusic: Lymphocytic hypophysitis and other inflammatory conditions of the pituitary
2.5: Susan M Webb, Anna Aulinas, Cristina Colom, and José Barahona: Pineal physiology and pathophysiology, including pineal tumours
3. The Thyroid
3.1: Evaluation of the thyroid patient
3.1.1: Robert Volpé and Clark Sawin: The history and iconography relating to the thyroid gland
3.1.2: W. Edward Visser: Biosynthesis, transport, metabolism, and actions of thyroid hormones
3.1.3: Inge Bülow Pedersen and Stig Andersen: Clinical assessment of the thyroid patient
3.1.4: Ulla Feldt-Rasmussen: Thyroid function tests and the effects of drugs
3.1.5: Robin P. Peeters and Anita Boelen: Nonthyroidal illness syndrome
3.1.6: Steen Bonnema and Laszlo Hegedüs: Thyroid imaging: nuclear medicine techniques
3.1.7: Laszlo Hegedüs and Finn N. Bennedbæk: Thyroid imaging: nonisotopic techniques
3.1.8: Mark P. J. Vanderpump: Epidemiology of thyroid disease and swelling
3.2: Aetiology of thyroid disorders
3.2.1: Terry Davies, Francesca Menconi, and Yaron Tomer: The complex genetics of thyroid disease
3.2.2: Josef Köhrle: Environmental factors
3.2.3: Michael B. Zimmermann: Iodine deficiency disorders
3.2.4: Shunichi Yamashita, Furio Pacini, and Rossella Elisei: Radiation-induced thyroid disease
3.2.5: Anthony P. Weetman: Autoimmune thyroid disease
3.2.6: Elizabeth N. Pearce and Alan Farwell: Thyroiditis
3.3: Thyrotoxicosis and related disorders
3.3.1: Claudio Marcocci and Filomena Cetani: Clinical assessment and systemic manifestations of thyrotoxicosis
3.3.2: Annie W. C. Kung and C.L. Cheung: Thyrotoxic periodic paralysis
3.3.3: Leonard Wartofsky, Dorina Ylli, and Joanna Klubo-Gwiezdzinska: Thyrotoxic storm
3.3.4: Simon Pearce: Subclinical hyperthyroidism
3.3.5: Francesco Latrofa and Paolo Vitti: Causes and laboratory investigations of thyrotoxicosis
3.3.6: Luigi Bartalena: Anti-thyroid drug treatment for thyrotoxicosis
3.3.7: Markus Luster and Michael Lassmann: Radio-iodine treatment of hyperthyroidism
3.3.8: Nancy Dugal Perrier, Orlo Clark, and Sarah B. Fisher: Surgery for thyrotoxicosis
3.3.9: Jacques Orgiazzi: Management of Graves hyperthyroidism
3.3.10: Wilmar M. Wiersinga: Graves orbitopathy and dermopathy
3.3.11: Dagmar Führer and Holger Jäschke: Management of toxic multinodular goitre and toxic adenoma
3.3.12: Wilmar M. Wiersinga: Management of thyrotoxicosis without hyperthyroidism
3.4: Hypothyroidism
3.4.1: Massimo Tonacchera and Luca Chiovato: Clinical assessment and systemic manifestations of hypothyroidism
3.4.2: Ferruccio Santini: Causes and laboratory investigation of hypothyroidism
3.4.3: Leonard Wartofsky, Dorina Ylli, and Joanna Klubo-Gwiezdzinska: Myxoedema coma
3.4.4: Bijay Vaidya and Chantal Daumerie: Subclinical hypothyroidism
3.4.5: Mark Gurnell, Carla Moran, and V. K. Chatterjee: Syndromes of Resistance to Thyroid Hormone
3.4.6: Birte Nygaard: Treatment of hypothyroidism
3.5: Thyroid lumps
3.5.1: Dagmar Führer and Holger Jäschke: Pathogenesis of nontoxic goitre
3.5.2: Hans Graf and Gilberto Paz Filho: Management of nontoxic multinodular goitre
3.5.3: Laszlo Hegedüs and Finn N. Bennedbæk: Management of the single thyroid nodule
3.5.4: Massimo Santoro, Barbara Jarzab, Jolanta Krajewska, and Dagmara Rusinek: Pathogenesis of thyroid cancer
3.5.5: Fulvio Basolo and Clara Ugolini: Pathology of thyroid cancer
3.5.6: Corin Badiu and Ruxandra Dobrescu: Papillary, follicular, and anaplastic thyroid carcinoma and lymphoma
3.5.7: Friedhelm Raue and Karin Frank-Raue: Medullary thyroid carcinoma
4. Parathyroid, calcium, and bone metabolism
4.1: David Goltzman and Geoffrey N. Hendy: Parathyroid anatomy, hormone synthesis, secretion, action, and receptors
4.2: Claudio Marcocci, Federica Saponaro, and Filomena Cetani: Hypercalcaemia
4.3: John P. Bilezikian: Primary hyperparathyroidism
4.4: Dolores Shoback and Muriel Babey: Familial Hypocalciuric Hypercalcemia Types 1-3 and Neonatal Severe Primary Hyperparathyroidism
4.5: Rajesh Thakker, Bart Clarke, and Fadil M. Hannan: Hypocalcaemic disorders, hypoparathyroidism, and pseudohypoparathyroidism
4.6: Paul D. Miller and Michael Pazianas: Bones and the KidneyDLThe Practical Conundrum: Distinguishing Between Osteoporosis and the Bone Diseases that Accompany Chronic Renal Failure
4.7: Laleh Ardeshirpour, Thomas O. Carpenter, and Cemre Robinson: Hypercalcaemic and hypocalcaemic syndromes in children
4.8: Richard Eastell: Osteoporosis
4.9: Graham R. Williams, J. H. Duncan Bassett, Bernard Freudenthal, and Laura M. Watts: Thyroid disorders and bone disease
4.10: Socrates E. Papapoulos: Paget s disease of bone
4.11: Michael P. Whyte: Rickets and osteomalacia (acquired and heritable forms)
4.12: Gherardo Mazziotti, Ernesto Canalis, and John P. Bilezikian: Glucocorticoid-induced osteoporosis
5. The adrenal gland and endocrine hypertension
5.1: Peter Guest: Adrenal imaging
5.2: Fausto Palazzo and Radu Mihai: Adrenal surgery
5.3: Irina Bancos, Massimo Terzolo, and Wiebke Arlt: Adrenal incidentaloma
5.4: Jérôme Bertherat, Rossella Libè, and Anne Jouinot: Adrenocortical cancer
5.5.1: Eamonn R. Maher and Ruth T Casey: Genetics of phaeochromocytomas, paragangliomas, and neuroblastoma
5.5.2: Henri Timmers: Management of phaeochromocytoma and paragagnlioma
5.6.1: Maria Christina Zennaro, Fabio Fernandes-Rosa, and Sheerazed Boulkroun: Genetics of primary aldosteronism and other steroid-related causes of endocrine hypertension
5.6.2: Morris Brown and Will Drake: Management of primary aldosteronism
5.7: John Newell-Price: Cushing s syndrome
5.8.1: Li Chan and Shwetha Ramachandrappa: Genetics of Adrenal Insufficiency
5.8.2: Wiebke Arlt: Management of Adrenal Insufficiency
5.9.1: Nils P. Krone: Genetics of congenital adrenal hyperplasia
5.9.2: Richard J. Auchus: Modern management of congenital adrenal hyperplasia and prospects for the future
6. Neuroendocrine tumours and genetic disorders
6.1: Guido Rindi and Rajaventhan Srirajaskanthan: Overview and Pathophysiology of Neuroendocrine Neoplasms
6.2: Whaljit Dhillo and Paul Bech: Neuroendocrine tumour markers
6.3: Rajaventhan Srirajaskanthan, Martyn E. Caplin, and Dominique Clement: Carcinoid syndrome
6.4.1: Juan W. Valle, Kok Haw Jonathan Lim, and Wasat Mansoor: Lung neuroendocrine tumours
6.4.2: Juan W. Valle, Kok Haw Jonathan Lim, and Wasat Mansoor: Non-functioning pancreatic neuroendocrine tumours
6.5: Christos Toumpanakis and Martyn E. Caplin: Gastrinoma
6.6: Ashley Grossman and Ingrid YF Mak: Insulinoma and hypoglycaemia
6.7: Karim Meeran: Glucagonoma
6.8: Alia Munir: Vasointestinal Polypeptide Secreting Tumours
6.9: John Wass: Somatostatinoma
6.10: Prakash Manoharan: Imaging neuroendocrine tumours of the gastrointestinal tract/gastroenteropancreatic neuroendocrine tumours (GEP-NET)
6.11: Rajesh V. Thakker: Multiple endocrine neoplasia type 1
6.12: Electron Kebebew, Douglas Wiseman, and Mustapha El Lakis: Multiple endocrine neoplasia type 2a and 2b
6.13: Eamonn R. Maher and Ruth T. Casey: Familial syndromes and genetic causes of paraganglioma and phaeochromocytoma
6.14: Constantine A. Stratakis and Fabio Faucz: Carney s complex
6.15: Michael A. Levine and Steven A. Lietman: Molecular and Clinical Characteristics Of the McCune-Albright Syndrome
6.16: Charis Eng, Lamis Yehia, and Shreya Malhotra: Cowden syndrome
7. Growth and development during childhood and adolescence
7.1: Growth and its Disorders
7.1.1: Gary Butler: Recognising Normal and Disordered Growth
7.1.2: Alexander A. L. Jorge, Fernanda A. Correa, and Renata C. Scalco: Disorders of the GH-IGF Axis
7.1.3: Anita Hokken-Koelega: Short stature in children born small for gestational age
7.1.4: Steve Chernausek and Minu George: Growth Disorders with no defined aetiology
7.1.5: Lars Savendahl and Emelie Benji: Tall Stature
7.2: Sex Development
7.2.1: Olaf Hiort and Ralf Werner: Sex Determination and Differentiation
7.2.2: S. Faisal Ahmed and Salma R. Ali: Disorders of Sex Development (DSD) in the newborn
7.2.3: Alan Rogol and John Fuqua: Recognising Normal and Disordered Pubertal Development
7.2.4: Alan Rogol and John Fuqua: Pubertal Delay and Hypogonadism
7.2.5: Julianne Leger and Jean-Claude Carel: Precocious Puberty
7.3: Helena Gleeson and Rohana Wright: Transition In Endocrinology
8. Female endocrinology and pregnancy
8.1: Normal female endocrinology and ovarian disorders
8.1.1: Chris McCartney and John Marshall: Neuroendocrinology of reproduction: the role of hypothalamus and pituitary
8.1.2: Terhi Piltonen and Juha Tapanainen: Ovarian and uterine development from fetal life to puberty
8.1.3: Gurkan Bozdag, Baris Ata, and Engin Türkgeldi: Menstrual cycle and ovulation
8.2: Evaluation of the female patient with suspected reproductive endocrine disorders
8.2.1: Channa Jayasena, Steve Franks, and Rachel Roberts: Clinical evaluation of patient with suspected reproductive endocrine disorders
8.2.2: Daniel Dumesic and Zain Al-Safi: Laboratory evaluation
8.3: Reproductive endocrine disorders
8.3.1: Sarah L. Berga: Disorders of gonadotrophin secreton
8.3.2: Julian R. E. Davis and Agnieszka Swiecicka: Hyperprolactinaemia
8.3.3: Deepthi Lavu, Radha Indusekhar, and Shaughn O'Brien: Premenstrual syndrome
8.4: Polycystic ovary syndrome and other androgen excess disorders
8.4.1: Bulent Yildiz and Sezcan Mumusoglu: Polycystic ovary syndrome: definitions, phenotypes, prevalence and genetics
8.4.2: R Jeffrey Chang: Polycystic ovary syndrome: reproductive aspects
8.4.3: David Ehrmann and Susan Sam: Polycystic ovary syndrome: metabolic aspects
8.4.4: Duarte Pignatelli, Ricardo Azziz, and Bulent Yildiz: Polycystic ovary syndrome: Hirsutism
8.5: Female hypogonadism and menopause
8.5.1: Ephia Yasmin and Gerard S. Conway: Female hypogonadism: premature ovarian insufficiency
8.5.2: Dimitrios G. Goulis, Stavroula A. Paschou, and Panagiotis Anagnostis: Female hypogonadism: Endocrinology of the menopause and hormone replacement therapy
8.6: Female infertility
8.6.1: Adam Balen and Susie Jacob: Female Infertility and assisted reproduction
8.6.2: Kutluk Oktay and Enes Taylan: Female infertility: fertility preservation
8.7: Hormonal contraception
8.7.1: Jennifer Chin Bliss Kaneshiro: Hormonal contraception
8.8: Exogenous factors and female repoductive health
8.8.1: Alessandra Gambineri and Daniela Ibarra-Gasparini: Exogenous factors and female reproductive health: common extragonadal endocrinopathies affecting reproduction
8.8.2: Siew Lim, Aya Mousa, Soulmaz Shorakae, and Lisa Moran: Exogenous factors and female reproductive health: nutrition and reproduction
8.8.3: Evy Diamanti-Kandarakis and Eleni A Kandaraki: Exogenous factors and female reproductive health: envrionment and reproduction
9. Endocrinology of pregnancy
9.1: Endocrine disorders of Pregnancy
9.1.1: Peter Taylor, LDKE Premawardhana, and John Lazarus: General considerations relating to thyroid disease in pregnancy
9.1.2: Kris Poppe, Flora Veltri, and David Unuane: Management of thyroid disorders before assisted and spontaneous pregnancy
9.1.3: Tim Korevaar and Robin Peeters: Thyroid disease during pregnancy
9.1.4: Nobuyuki Amino and Naoko Arata: Management of thyroid disorders after pregnancy
9.1.5: A. S. Paul van Trotsenburg Nitash and Zwaveling-Soonawala: Thyroid disorders in newborns, infants and children
9.1.6: Mark Molitch and Wenyu Huang: Pituitary tumours in pregnancy
9.1.7: Paul Carroll, Niki Karavitaki, and Kirstie Lithgow: Other disorders of the pituitary and hypothalamus in pregnancy
9.1.8: David Torpy, Michael O'Reilly, and Sunita De Sousa: Adrenal disease in pregnancy
9.1.9: Jeremy Cox and Stephen Robinson: Endocrine bone disease in pregnancy
9.1.10: Sandra Lowe: Imaging of endocrine disorders in pregnancy
10. Male Reproductive Endocrinology
10.1: Normal male reproductive endocrinology
10.1.1: Ilpo Huhtaniemi and Jorma Toppari: Endocrine and local regulation of testicular hormone and sperm production
10.1.2: Dirk Vanderschueren, Leen Antonio, Nari Kim, and Frank Claessens: Sex steroid actions in the Male
10.2: Evaluation of the male patient with suspected hypogonadism and/or infertility
10.2.1: Bradley Anawalt: Clinical evaluation
10.2.2: Jean-Marc Kaufman: Endocrine evaluation
10.2.3: Jackson Kirkman-Brown and Sarah J Conner: Diagnostic Semen analysis
10.3: Male reproductive endocrine disorders
10.3.1: Claus H. Gravholt: Klinefelter s syndrome
10.3.2: Adult Hypogonadism: Aetiology
10.3.2.1: Alvin Matsumoto and Radhika Narla: Etiology of Hypogonadism
10.3.2.2: Giovanni Corona, Mario Maggi, and Giulia Rastrelli: Types of Treatments
10.3.2.3: Michael Zitzmann: Gonadotrophin induction of spermatogenesis
10.3.2.4: Shehzad Basaria and Thiago Gagliano-Juca: Male Hypogonadism: Benefits of Testosterone Treatment
10.3.2.5: Adrian Dobs and Swaytha Yalamanchi: Risks of T Treatment
10.3.3: Herman J. Tournaye and Biljana Popovic-Todorovic: Management of Idiopathic male infertility
10.3.4: Mathis Grossmann, B. Yeap, and Gary Wittert: Hypothalamo-pituitary-testicular axis fucntion in systemic diseases and effects of medications
10.3.5: Vincenzo Rochira, Antonio R. M. Granata, and Cesare Carani: Management of sexual dysfunction
10.3.6: Stephanie Page and Maritza Farrant: Hormonal male contraception
10.3.7: Glenn Braunstein: Gynaecomastia
10.4: Exogenous factors and male reproductive health
10.4.1: Jorma Toppari: Environmental influences on male reproductive health
10.4.2: David Handelsman: Androgen Misuse and Abuse
11. Management of the Transgender Patient
11.1: Jon Arcelus and Walter Bouman: Introduction to Transgender and Gender Diverse People
11.2: Daniel Klink: Endocrine Treatment of Transgender Youth
11.3: Vin Tangpricha and Craig Sineath: Hormone Therapy in transgender women
11.4: Guy T'Sjoen and Justine Defreyne: Hormone therapy in transgender men
11.5: Chloë De Roo and Guy T'Sjoen: Fertility Options for Transgender Persons
12. Endocrine Responses to Systemic Diseases or Substance Use
12.1: Endocrinology of systemic disease
12.1.1: David Henley, Thomas Upton, and Stafford L. Lightman: The endocrine response to stress
12.1.2: Greet Van den Berghe and Lies Langouche: Endocrinology in the critically ill
12.1.3: David Johnson, Melissa Nataatmadja, and Yeoungjee Cho: Hormones and the kidney
12.1.4: Jacob George and Mohammed Eslam: The endocrinology of liver disease
12.1.5: Steven K. Grinspoon and Takara Stanley: Endocrine abnormalities in HIV infection
12.1.6: Karen Miller: The endocrinology of anorexia nervosa
12.2: Endocrine Complications of Substance Misuse
12.2.1: Marc Walter and Margit Proescholdt: Endocrinology and alcohol
12.2.2: Peter Sonksen and Richard Holt: Use and abuse of performance-enhancing hormones in sport
12.2.3: Ashley Grossman, Eleni Armeni, and Bernard Khoo: Effect of Opioids on Adrenal and Reproductive Endocrinology
13. Endocrinology of cancer
13.1: Endocrine Disorders Caused by Cancer or its Treatment
13.1.1: Thomas Papathomas and Vania Nose: Metastatic Disease in Endocrine Organs
13.1.2: David W. Ray: Paraneoplastic endocrine syndromes
13.1.3: Claire Higham and Rob Murray: Long-term endocrine sequelae of cancer therapy
13.1.4: Carla Moran: Endocrine complications of biological cancer therapies
13.2: Hormonal therapy for breast and prostatic cancers
13.2.1: Rob Clarke and Alice Greenhalgh: The breast: lactation and breast cancer as an endocrine disease
13.2.2: Amna Sheri and Laura Morrison: Endocrine treatment of breast cancer
13.2.3: Irina A. Vasilevskaya, Matthew J. Schiewer, and Karen E. Knudsen: Hormonal Therapy for Prostate Cancer: Molecular basis of efficacy and therapeutic bypass
14. Obesity, lipids, and metabolic disorders
14.1: Obesity
14.1.1: Anthony Coll: The Physiology of Bodyweight Regulation
14.1.2: Adrian Bauman: Obesity as a Public Health Problem
14.1.3: Rachel Batterham and Friedrich Jassil: Medical Complications of Obesity
14.1.4: John Wilding and Jonathan Lim: Dietary and Medical Management of Obesity
14.1.5: Francesco Rubino, Vivian Anastasiou, Luca Ferraro, Dalal Qanaq, and Ghassan Chamseddine: Metabolic Surgery
14.1.6: Sadaf Farooqi: Assessment of Obesity in Children
14.1.7: Russell Viner and Billy White: Management of Obesity in Children and Young People
14.1.8: Nick Finer: Planning obesity care pathways
14.2: Lipoprotein metabolism and dyslipidaemia
14.2.1: Bo Angelin and Paolo Parini: Lipoprotein metabolism
14.2.2: Stefano Romeo, Bo Angelin, and Paolo Parini: Genetic forms of dyslipidaemia
14.3: Other metabolic disorders
14.3.1: Khalid Hussain and Sonya Galcheva: Hyperinsulinaemic Hypoglycaemia
14.3.2: Phillip Gorden and Noemi Malandrino: Autoimmune Hypoglycaemia
14.3.3: Robin H. Lachmann: Disorders of carbohydrate metabolism
14.3.4: Yves Deugnier and Edouard Bardou-Jacquet: Haemochromatosis And Other Inherited Diseases Of Iron Metabolism
14.3.5: Michael N. Badminton and Danja Schulenburg-Brand: The porphyrias
15. Diabetes mellitus
15.1: Introduction to Diabetes Mellitus
15.1.1: Shanta Persaud and Peter Jones: Physiology of glucose homeostasis
15.1.2: Stephen Colagiuri and Crystal Man Ying Lee: Classification and diagnosis of diabetes mellitus
15.2: Aetiopathogenesis and Diagnosis of Type 1 Diabetes
15.2.1: Elizabeth J. Mayer-Davis and Daria Igudesman: Epidemiology and Public Health
15.2.2: Augustin Brooks: Presentation and Natural History
15.2.3: Richard Oram, Susan Wong, and Ayat Bashir: Pathogenesis
15.3: Aetiopathogenesis and Diagnosis of Type 2 Diabetes
15.3.1: Sarah Wild and Jackie Price: Epidemiology and Public Health
15.3.2: Roy Taylor: Presentation and Natural History
15.3.3: Mark Walker, Xuefei Yu, and Amalia Gastaldelli: Pathogenesis
15.4: Non Type 1, Non Type 2 Diabetes
15.4.1: Katherine Owen: Diagnosis of non type 1, non type 2 forms of diabetes
15.5: Principles of Management of Diabetes
15.5.1: Simon Heller and Jackie Elliott: Structured Education
15.5.2: John Pickup and Nick Oliver: Glucose Monitoring and Sensing
15.5.3: Pratik Choudhary and Peter Jacob: Insulins and insulin delivery devices
15.5.4: Clifford Bailey and Melanie Davies: Non-insulin glucose lowering agents
15.5.5: Stephanie Amiel: Hypoglycaemia in the treatment of diabetes mellitus
15.6: Evidence-based Management of Type 1 Diabetes
15.6.1: Peter Hammond and Fiona Campbell: Strategies for management of type 1 diabetes
15.6.2: Christel Hendrieckx and Jane Speight: Psychological and Behavioural Aspects of Type 1 Diabetes Management
15.6.3: Colin Dayan and Danijela Tatovic: Immunotherapy for type 1 diabetes
15.6.4: Peter Senior, Martin Drage, Anneliese Flatt, and Chris Callaghan: Transplantation (islet and solid organ)
15.7: Evidence-based Prevention and Management of Type 2 Diabetes
15.7.1: Peter Winocour and Sagen Zac-Varghese: Strategies for management of type 2 diabetes
15.7.2: Jane Speight and Tim Skinner: Psychological and Behavioural Aspects of Type 2 Diabetes Management
15.7.3: Kamiesh Khunti and Nitin Narayan Gholap: Type 2 diabetes in different ethnic groups
15.7.4: Nicholas Wareham: Prevention of Type 2 Diabetes
15.8: Emerging Approaches to Restoring Euglycaemia in Diabetes
15.8.1: Michael White, Timothy J. Kieffer, and Cara Ellis: Regenerative medicine for diabetes
15.8.2: Roman Hovorka and Charlotte Boughton: Closed loop
15.9: Emergency and Hospital management of Diabetes
15.9.1: Ketan Dhatariya: Hyperglycaemic Emergencies
15.9.2: Gerry Rayman: Management of the inpatient with diabetes mellitus
15.9.3: Greet Van Den Berghe and Jan Gunst: Care of diabetes in ICU and peri-sugery
15.10: Specialised Management of Other forms of Diabetes
15.10.1: Andrew Hattersley, Kashyap Patel, and Rachel Besser: Monogenic forms of diabetes resulting from beta cell dysfunction
15.10.2: Anna Stears, David B. Savage, and Stephen O'Rahilly: Lipodystrophies and severe insulin resistance
15.10.3.1: Phil Weston: Diabetes Secondary to Pancreatic Disease
15.10.3.2: Jeremy Tomlinson: Diabetes Secondary to Endocrine Disorders
15.10.4: Helen Murphy and Jennifer M Yamamoto: Diabetes in Pregnancy
15.11: Psychiatry and Diabetes
15.11.1: Khalida Ismail, Christopher Garrett, and Marietta Stadler: Type 1 diabetes and Psychiatry
15.11.2: Khalida Ismail, Hermione Price, Marilia Calcia, Calum Moulton, and Clare Whicher: Type 2 diabetes and Psychiatry
15.12: Microvascular Complications of Diabetes
15.12.1: Angela Shore: Pathogenesis of Microvascular Complications
15.12.2: Peter Scanlon: Retinopathy
15.12.3: Luigi Gnudi and Sally Marshall: Diabetic Nephropathy
15.12.4: Solomon Tesfaye and Jing Wu: Diabetic Neuropathy
15.13: Macrovascular Disease in Diabetes
15.13.1: Mark Kearney, Peysh Patel, and Richard Cubbon: Mechanisms of macrovascular disease in diabetes
15.13.2: Naveed Sattar: Macrovascular disease in type 2 diabetes
15.13.3: John Petrie: Macrovascular disease in type 1 diabetes
15.13.4: Bruno Vergès: Diabetic dyslipidaemia
15.13.5: Bryan Williams: Hypertension in diabetes mellitus
15.14: The Diabetic Foot
15.14.1: Frank Bowling and Andrew Boulton: Modern management of diabetes-related foot disease
15.15: Delivery of Diabetes Care
15.15.1: Jonathan Valabhji: Diabetes service organisation
15.15.2: Philip Clarke and Tom Lung: Health Economics of Diabetes Care and Prevention
Les mer